Protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene R620W variant and sporadic idiopathic hypoparathyroidism in Asian Indians

International Journal of Immunogenetics

Volumn 33, Issue 4, 2006, Pages 237-240

  Ray, D ^a   Tomar, N ^a   Gupta, N ^a   Goswami, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 22; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ASIAN; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; DISEASE DURATION; ETHNIC GROUP; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOPARATHYROIDISM; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOPARATHYROIDISM; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33746110780     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2006.00604.x     Document Type: Article

References (27)

1. Ban, Y., Tozaki, T., Taniyama, M., Tomita, M. & Ban, Y. (2005) The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid, 15, 1115.
2. Begovich, A.B., Carlton, V.E., Honigberg, L.A., Schrodi, S.J., Chokkalingam, A.P., Alexander, H.C. et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. American Journal of Human Genetics, 75, 330.
3. Betterle, C., Dal Pra, C., Mantero, F. & Zanchetta, R. (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews, 23, 327.
4. Bjerneroth, G., Juhlin, C., Rastad, J., Akerstrom, G. & Klareskog, L. (1993) MHC class land II antigen expression on parathyroid cells and prospects for their allogenic transplantation. Transplantation, 56, 717.
5. Blizzard, R.M., Chee, D. & Davis, W. (1966) The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clinical and Experimental Immunology, 1, 119.
6. Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M. et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics, 36, 337.
7. Brandi, M.L., Aurbach, G.D., Fattorossi, A., Quarto, R., Marx, S.J. & Fitzpatrick, L.A. (1986) Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. Proceedings of the National Academy of Sciences USA, 83, 8366.
8. Canton, I., Akhtar, S., Gavalas, N.G., Gawkrodger, D.J., Blomhoff, A., Watson, P.F., Weetman, A.P. & Kemp, E.H. (2005) A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes and Immunity, 6, 584.
9. Cloutier, J.F. & Veillette, A. (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. Journal of Experimental Medicine, 189, 111.
10. Criswell, L.A. & Gregersen, P.K. (2005) Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developments. Rheumatology (Oxford), 44 (Suppl. 4), 9.
11. Goswami, R., Brown, E.M., Kochupillai, N., Gupta, N., Rani, R., Kifor, O. & Chattopadhahy, N. (2004a) Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. European Journal of Endocrinology, 154, 9.
12. Goswami, R., Gupta, N., Ray, D., Rani, R., Tomar, N., Sarin, R. & Vupputuri, M.R. (2005) Polymorphisms at +49A/G and CT60 sites in the 3′ UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism. International Journal of Immunogenetics, 32, 393.
13. Goswami, R., Mohapatra, T., Gupta, N., Rani, R., Tomar, N., Dikshit, A. & Sharma, R.K. (2004b) Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism, 89, 4840.
14. Goswami, R., Srikanta, S.S. & Kochupillai, N. (1995) Prevalence and significance of pancreatic islet cell and adrenal antibodies in patients with Graves' disease. Indian Journal of Medical Research, 101, 201.
15. Gregersen, P.K. (2005) Gaining insight into PTPN22 and autoimmunity. Nature Genetics, 37, 300.
16. Hasegawa, K., Yajima, H., Katagiri, T., Ogimoto, M., Arimura, Y., Mitomo, K., Mashima, K., Mizuno, K. & Yakura, H. (1999) Requirement of PEST domain tyrosine phosphatase PEP in B cell antigen receptor-induced growth arrest and apoptosis. European Journal of Immunology, 29, 887.
17. Kyogoku, C., Langefeld, C.D., Ortmann, W.A., Lee, A., Selby, S., Carlton, V.E. et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. American Journal of Human Genetics, 75, 504.
18. Li, Y., Song, Y.H., Rais, N., Connor, E., Schatz, D., Muir, A. & Maclaren, N. (1996) Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with sacquired hypoparathyroidism. Journal of Clinical Investigation, 97, 910.
19. Mayer, A., Ploix, C., Orgiazzi, J., Desbos, A., Moreira, A., Vidal, H., Monier, J.C., Bienvenu, J. & Fabien, N. (2004) Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism, 89, 4484.
20. Perheentupa, J. (2002) APS-I/APECED: the clinical disease and therapy. Endocrinology and Metabolism Clinics of North America, 31, 295.
21. Peterson, P., Pitkanen, J., Sillanpaa, N. & Krohn, K. (2004) Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clinical and Experimental Immunology, 135, 348.
22. Siminovitch, K.A. (2004) PTPN22 and autoimmune disease. Nature Genetics, 36, 1248.
23. Ueda, H., Howson, J.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G. et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506.
24. Vang, T., Congia, M., Macis, M.D., Musumeci, L., Orru, V., Zavattari, P. et al. (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nature Genetics, 37, 1317.
25. Velaga, M.R., Wilson, V., Jennings, C.E., Owen, C.J., Herington, S., Donaldson, P. et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 89, 5862.
26. Wortsman, J., McConnachie, P., Baker, J.R. Jr & Mallette, L.E. (1992) T-lymphocyte activation in adult-onset idiopathic hypoparathyroidism. American Journal of Medicine, 92, 352.
27. Zheng, W. & She, J.X. (2005) Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes, 54, 906.